±è¿ëÁø

  • ºí·Î±×
±è¿ëÁø
¼¼ºÎÀü°ø
»ý½Ä³»ºÐºñÇÐ, ³­ÀÓ, ÀϹݺÎÀΰúÇÐ
Áúȯ±º
³­ÀÓ, °¡ÀÓ±â Á¾¾ç, °¡ÀÓ·Â º¸Á¸, ¿ù°æÀå¾Ö, Àڱ󻸷Áõ, ÀڱñÙÁ¾, ¼±±ÙÁõ, ¾ç¼º ³­¼Ò Á¾¾ç, °»³â±â Àå¾Ö
Áõ»ó±º
³­ÀÓ, °¡ÀÓ·Â º¸Á¸, ¹Ýº¹ ÀӽŠ½ÇÆÐ, ¹Ýº¹ À¯»ê, ½ÃÇè°ü ½Ã¼ú, °ú´Ù¿ù°æ, ¿ù°æÅë, ¹«¿ù°æ, ¹è¶õÀå¾Ö, °ñ¹ÝÅë, ÇϺ¹ºÎÅëÁõ, ÁúÃâÇ÷, °»³â±âÁõ»ó, °ñ´Ù°øÁõ

±è¿ëÁø ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
»êºÎÀΰú
¿ÀÀü
¿ÀÀü
¿ÀÀü
¿ÀÈÄ
- - ºÒÀÓ, »ý½Ä³»ºÐºñÁúȯ, Æó°æ, °¡Àӱ⿩¼ºÁ¾¾ç, °¡Àӷº¸Á¸, ·Îº¿-º¹°­°æ¼ö¼ú

±è¿ëÁø ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1991  ~  1998  :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú Çлç
  • 2007  ~  2009  :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ¼®»ç
  • 2009  ~  2012  :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ¹Ú»ç

°æ·Â

more
  • 2002  ~  2006  :  ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú Àü°øÀÇ
  • 2006  ~  2007  :  ºÐ´ç¼­¿ï´ëº´¿ø »êºÎÀΰú ÀüÀÓÀÇ
  • 2007  ~  2009  :  ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ÀüÀÓÀÇ
  • 2008  ~  2010  :  ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãѹ«°£»ç
  • 2009  ~  2010  :  ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú Áø·á±³¼ö
  • 2009  ~  2012  :  ¼­¿ï´ëÇб³ ÀÇÇבּ¸¿ø ¼±ÀÓ¿¬±¸¿ø
  • 2010  ~  2012  :  ¼­¿ï ¸¶¸®¾Æ º´¿ø °úÀå
  • 2012  ~  2015  :  °í·Á´ëÇб³ ±¸·Îº´¿ø »êºÎÀΰú ÀÓ»óÁ¶±³¼ö
  • 2015  ~  2019  :  °í·Á´ëÇб³ ±¸·Îº´¿ø »êºÎÀΰú ÀÓ»óºÎ±³¼ö
  • 2019  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø »êºÎÀΰú ±³¼ö

¼ö»ó³»¿ª

more
  • 2005  :  ´ëÇÑ»ý½ÄÀÇÇÐȸ Çмú´ëȸ ¿ì¼ö Æ÷½ºÅÍ»ó
  • 2009  :  ´ëÇÑ»ý½ÄÀÇÇÐȸ Çмú´ëȸ ¿ì¼ö Æ÷½ºÅÍ»ó
  • 2010  :  Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ °úÇбâ¼ú¿ì¼ö³í¹®»ó
  • 2011  :  ´ëÇѺ¸Á¶»ý½ÄÇÐȸ Çмú´ëȸ ÀþÀº¿¬±¸ÀÚ»ó
  • 2018  :  ´ëÇÑÁ¶Á÷°øÇÐÀç»ýÀÇÇÐȸ Nature Springer Award

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇÑ»êºÎÀΰúÇÐȸ
  •  ~   :  ´ëÇÑ»ý½ÄÀÇÇÐȸ
  •  ~   :  ´ëÇÑÆó°æÇÐȸ
  •  ~   :  ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ
  •  ~   :  ´ëÇÑ»ý½Äº¸°ÇÇÐȸ
  •  ~   :  ´ëÇѺ¸Á¶»ý½ÄÇÐȸ
  •  ~   :  ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ
  •  ~   :  ´ëÇÑÁ¶Á÷°øÇÐÀç»ýÀÇÇÐȸ

³í¹®

more
  • [SCI] (Induction of multiple ovulation via modulation of angiotensin II receptors in in vitro ovarian follicle culture models)
  • [SCI] (Profile of MicroRNA Expression in Endometrial Cell during In Vitro Culture According to Progesterone Concentration)
  • [SCI] (Predictive value of serum progesterone level on ¥â-hCG check day in women with previous repeated miscarriages after in vitro fertilization)
  • [SCI] Effects of Estradiol on the Paracrine Regulator Expression of In Vitro Maturated Murine Ovarian Follicles
  • [SCI] (The expression profile of angiotensin system on thawed murine ovaries)
  • [SCI] (MicroRNA Profile of Granulosa Cells after Ovarian Stimulation Differs According to Maturity of Retrieved Oocytes)
  • [SCI] (Indications of Intrauterine Insemination for Male and Non-Male Factor Infertility)
  • [SCI] (MicroRNAs transfected into granulosa cells may regulate oocyte meiotic competence during in vitro maturation of mouse follicles)
  • [SCI] (Incidence of Bartholin duct cysts and abscesses in the Republic of Korea)
  • [SCI] (Association between socioeconomic status and ectopic pregnancy rate in the Republic of Korea)
  • [SCI] (Effects of Urinary and Recombinant Gonadotropins on In Vitro Maturation Outcomes of Mouse Preantral Follicles)
  • [SCI] (Effects of Alginate Hydrogels on In Vitro Maturation Outcome of Mouse Preantral Follicles)
  • [SCI] (Tri-pronucleated zygotes may occur less frequently in LH activity-added cycles)
  • [SCI] (Increased responsiveness may be associated with 3PN embryos in both conventional IVF and ICSI cycles using GnRH agonist long protocols: a self-matched observational study)
  • [SCI] (MicroRNA expression profiles are altered by gonadotropins and vitamin C status during in vitro follicular growth)
  • [SCI] (Dynamics of early estradiol production may be associated with the outcomes of in vitro fertilization)
  • [SCI] (A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles)
  • [SCI] (Does a vitrified blastocyst stage embryo transfer program need hormonal priming for endometrial preparation?)
  • [SCI] (Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome)
  • [SCI] (Effects of adding LH activity to GnRH antagonist protocols may differ according to age)
  • [SCI] (Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage)
  • [±¹³»³í¹®] »ýÁã ³­Æ÷ÀÇ Ã¼¿Ü¹è¾ç Áß »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¿¡ µû¸¥ ¹Ì¼¼¸®º¸ÇÙ»ê ¹ßÇö ¾ç»ó
  • [±¹³»³í¹®] Æó°æ ¿©¼º¿¡¼­ µå·Î½ºÇÇ·¹³í°ú ¿¡½ºÆ®¶óµð¿Ã Áö¼ÓÀû º´ÇÕ¿ä¹ýÈÄ Ã¼Áß, Ç÷¾Ð ¹× Áö´Ü¹éÀÇ º¯È­¾ç»ó¿¡ ´ëÇÑ ¿¬±¸: ´Ù±â°ü, ÀÌÁ߸ͰË, ¹«ÀÛÀ§, À§¾à´ëÁ¶ ¿¬±¸
  • [±¹³»³í¹®] º¸Á¶»ý½Ä¼ú Áֱ⿡¼­ÀÇ °ú¹è¶õÀ¯µµ¸¦ À§ÇÑ ÀçÁ¶ÇÕ È²Ã¼È­È£¸£¸óÀÇ È¿¿ë¼º
  • [±¹³»³í¹®] ºÒÀӽüúÀÇ ÀüȯÀÌ Á¤¾×»óÅ¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • [±¹³»³í¹®] Osteoprotegerin (OPG)-receptor Activator of NF-kB Ligand (RANKL) À¯ÀüÀÚ ´ÙÇü¼º°ú ÀüÇ÷¼¼Æ÷¿¡¼­ÀÇ OPG, sRANKL »ý»ê »çÀÌÀÇ ¿¬°ü¼º
  • [±¹³»³í¹®] ü¿Ü¼öÁ¤½Ã¼úÀ» À§ÇÑ °ú¹è¶õÀ¯µµ½Ã Àú¿ë·® ¾Æ½ºÇǸ°°ú ºÎ½ÅÇÇÁúÈ£¸£¸ó Åõ¿©ÀÇ ÀÓ»óÀû È¿¿ë¼º

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.05.09